Airway Obstruction and Asthma Control Drive Exacerbation Risk in HDM-Sensitized Children

Article Impact Level: HIGH
Data Quality: STRONG
Summary of Journal of Occupational Medicine and Environmental Health https://doi.org/10.13075/ijomeh.1896.02867 
Dr. Katarzyna Gmachowska  et al.

Points

Medical University of Lodz researchers analyzed 80 pediatric patients with allergic rhinitis and asthma to identify predictors of frequent disease exacerbations over 12 months.
Patient cohorts were stratified by exacerbation frequency into groups experiencing fewer than two versus two or more exacerbations over a 12-month observation period.
Non-house-dust-mite-sensitized children with frequent exacerbations exhibited higher serum sRAGE concentrations and greater activity limitations secondary to severe sinonasal symptoms.
House-dust-mite-sensitized children with frequent exacerbations demonstrated impaired lung function with lower FEV1 values, reduced FEV1/FVC ratios, and poorer asthma control scores.
Upper respiratory tract symptom assessment alongside novel inflammatory biomarkers provides an effective framework for clinicians to improve pediatric asthma risk stratification.

Summary

This study evaluated the distinct physiological and inflammatory profiles associated with asthma exacerbation frequency in pediatric patients stratified by house dust mite (HDM) sensitization status. Pediatric asthma exacerbations represent a primary driver of disease burden, requiring precise biological and clinical markers for risk stratification. Led by Katarzyna Gmachowska, M.D., and colleagues at the Medical University of Lodz in Poland, the retrospective observational study investigated 80 children with co-occurring allergic rhinitis and asthma over a 12-month period to identify predictors of frequent disease exacerbations.

Participants were stratified into two distinct clinical cohorts based on exacerbation frequency over 12 months: non-frequent exacerbators (<2 exacerbations) and frequent exacerbators (≥2 exacerbations). Diagnostic evaluations included spirometry measuring forced expiratory volume in one second (FEV₁) and the FEV₁/forced vital capacity (FVC) ratio, fractional exhaled nitric oxide (FeNO), peripheral blood eosinophil counts, and serum soluble receptor for advanced glycation end products (sRAGE) concentrations. Additionally, researchers assessed sinonasal symptom severity and asthma control scores across both HDM-sensitized and non-sensitized subgroups.

The clinical predictors of frequent exacerbations differed markedly based on HDM sensitization status. In non-HDM-sensitized children, frequent exacerbations (≥2 over 12 months) significantly correlated with elevated serum sRAGE concentrations and greater activity limitation caused by severe sinonasal symptoms. Conversely, in HDM-sensitized children, frequent exacerbations were driven by airway obstruction and disease instability, characterized by lower baseline FEV₁, reduced FEV₁/FVC ratios, and poorer overall asthma control scores. The authors conclude that integrating upper respiratory symptom severity with inflammatory biomarkers like sRAGE optimizes exacerbation risk stratification in pediatric asthma management.

Link to the article: https://ijomeh.eu/Predictors-of-asthma-exacerbations-in-children-with-or-without-house-dust-mite-allergy,222736,0,2.html

References

Gmachowska, K., Socha-Wojtylak, I., Majak, P., & Jerzyńska, J. (2026). Predictors of asthma exacerbations in children with or without house dust mite allergy. International Journal of Occupational Medicine and Environmental Health, 39(3), 270–279. https://doi.org/10.13075/ijomeh.1896.02867